Facilitators and barriers to utilization of medications for opioid use disorder in primary care in South Carolina

被引:15
|
作者
Oros, Sarah M. [1 ,2 ]
Christon, Lillian M. [1 ]
Barth, Kelly S. [1 ]
Berini, Carole R. [3 ]
Padgett, Bennie L. [4 ]
Diaz, Vanessa A. [3 ]
机构
[1] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Dept Internal Med, Charleston, SC 29425 USA
[3] Med Univ South Carolina, Dept Family Med, Charleston, SC 29425 USA
[4] Med Univ South Carolina, Coll Med, Charleston, SC 29425 USA
来源
关键词
opioid use disorder; medication for opioid use disorder; primary care providers barriers; facilitators; internal medicine; family medicine; physician assistant; trainees; QUALITATIVE RESEARCH; UNITED-STATES; BUPRENORPHINE; SUBSTANCE; HEALTH; MANAGEMENT; ALCOHOL; INTERVIEWS; PREVENTION; CRITERIA;
D O I
10.1177/0091217420946240
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective Utilization of medications for opioid use disorder (MOUD) has not been widely adopted by primary care providers. This study sought to identify interprofessional barriers and facilitators for use of MOUD (specifically naltrexone and buprenorphine) among current and future primary care providers in a southeastern academic center in South Carolina. Method Faculty, residents, and students within family medicine, internal medicine, and a physician assistant program participated in focus group interviews, and completed a brief survey. Survey data were analyzed quantitatively, and focus group transcripts were analyzed using a deductive qualitative content analysis, based upon the theory of planned behavior. Results Seven groups (N = 46) completed focus group interviews and surveys. Survey results indicated that general attitudes towards MOUD were positive and did not differ significantly among groups. Subjective norms around prescribing and controllability (i.e., beliefs about whether prescribing was up to them) differed between specialties and between level of training groups. Focus group themes highlighted attitudes about MOUD (e.g., "opens the flood gates" to patients with addiction) and perceived facilitators and barriers of using MOUD in primary care settings. Participants felt that although MOUD in primary care would improve access and reduce stigma for patients, prescribing requires improved provider education and an integrated system of care. Conclusions The results of this study provide an argument for tailoring education to specifically address the barriers primary care prescribers perceive. Results promote the utilization of active, hands-on learning approaches, to ultimately promote uptake of MOUD prescribing in the primary care setting in South Carolina.
引用
收藏
页码:14 / 39
页数:26
相关论文
共 50 条
  • [1] Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care
    Tofighi, Babak
    Williams, Arthur Robin
    Chemi, Chemi
    Sindhu, Selena
    Dickson, Vicky
    Lee, Joshua D.
    [J]. SUBSTANCE USE & MISUSE, 2019, 54 (14) : 2409 - 2419
  • [2] Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review
    Mackey, Katherine
    Veazie, Stephanie
    Anderson, Johanna
    Bourne, Donald
    Peterson, Kim
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 3) : 954 - 963
  • [3] Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review
    Katherine Mackey
    Stephanie Veazie
    Johanna Anderson
    Donald Bourne
    Kim Peterson
    [J]. Journal of General Internal Medicine, 2020, 35 : 954 - 963
  • [4] Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings
    Speight, Chandra
    Caiola, Courtney
    Tyndall, Deborah E.
    Scott, Elaine S.
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2023, 35 (02) : 112 - 121
  • [5] Barriers and Facilitators to Using a Clinical Decision Support Tool for Opioid Use Disorder in Primary Care
    Hooker, Stephanie A.
    Solberg, Leif I.
    Miley, Kathleen M.
    Borgert-Spaniol, Caitlin M.
    Rossom, Rebecca C.
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2024, 37 (03) : 389 - 398
  • [6] Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder
    Fiddian-Green, Alice
    Gubrium, Aline
    Harrington, Calla
    Evans, Elizabeth A.
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (15)
  • [7] Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments
    Sasson, Comilla
    Dieujuste, Nathalie
    Klocko, Robert
    Basrai, Zahir
    Celedon, Manuel
    Hsiao, Jonie
    Himstreet, Julianne
    Hoffman, Jonathan
    Pfaff, Cassidy
    Malmstrom, Robert
    Smith, Jason
    Holstein, Ariel
    Johnson-Koenke, Rachel
    [J]. ACADEMIC EMERGENCY MEDICINE, 2023, 30 (04) : 289 - 298
  • [8] A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System
    Grella, Christine E.
    Ostile, Erika
    Scott, Christy K.
    Dennis, Michael
    Carnavale, John
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 81
  • [9] Barriers to Assessing and Treating Trauma in Primary Care and Opportunities for Improvement: Perspectives from Prescribers of Medications for Opioid Use Disorder
    Winiker, Abigail. K. K.
    Heidari, Omeid
    Pollock, Sarah
    Sodder, Shereen
    Tobin, Karin. E. E.
    [J]. SUBSTANCE USE & MISUSE, 2023, 58 (13) : 1651 - 1659
  • [10] Facilitators and barriers to adopting or expanding medications for opioid use disorder provision in rural Colorado jails: a qualitative analysis
    Mcneely, Heidi L.
    Schreiber, Terri L.
    Swann, William L.
    Amura, Claudia R.
    [J]. HEALTH & JUSTICE, 2024, 12 (01)